Parexel International Co

Nova Biomedical, based in Waltham, MA, specializes in the development, manufacturing, and sale of advanced analyzers across various healthcare sectors, including hospitals, critical care, and veterinary applications. The company's innovative product lineup features glucose and lactate monitoring systems, blood gas analyzers, and comprehensive solutions for cell culture analysis. Recently merged with Advanced Instruments, Nova Biomedical is committed to enhancing point-of-care testing and providing accurate results for medical professionals. The company continues to expand internationally, with significant investments in new technologies and global sales initiatives. Generated from the website

Repligen Corporation develops novel therapeutics for the treatment of diseases of the central nervous and immune systems. It provides clinical development programs for the areas of schizophrenia, obsessive-compulsive disorder, bipolar disorder, multiple sclerosis and lupus. Repligen markets two niche products, Protein A and SecreFlo. Protein A is a consumable reagent used by the pharmaceutical industry to manufacture a class of drugs called monoclonal antibodies. The company offers a number of products based on recombinant Protein A, which include recombinant Protein A, Immobilized Protein A and Protein A ELISA Kits. SecreFlo is approved by the Food and Drug Administration to aid in the diagnosis of pancreatic exocrine dysfunction and gastrinoma and to aid in the identification and cannulation of the pancreatic ducts in patients undergoing endoscopic retrograde cholangiopancreatography. Repligen Corporation was established in 1981 and is headquartered in Waltham, Mass.

Dimagi Inc is a Cambridge-based tech company that specializes in providing digital solutions for impactful frontline work in sectors such as healthcare, education, nutrition, and agriculture. With over 20 years of experience and a user-centered design approach, they offer advanced data collection and service delivery software that is easy to implement and scale. Their comprehensive range of services includes application design, rollout support, end-user training, and partner capacity building, ensuring a seamless program deployment. Dimagi's commitment to impact is evident in their evidence-based approach, with more studies assessing the impact of their mobile platform, CommCare, than any other platform for frontline workers.Generated from the website